AML Resources

Support Group Information

There are a variety of patient and caregiver support groups and resources available for information about AML:

Jazz Pharmaceuticals does not endorse and is not responsible for the content included in these resources. The foundations listed above are independent from Jazz, and the foundations’ award assistance, if any, is based on their own eligibility criteria without any influence or control by Jazz Pharmaceuticals.

Your healthcare team should always be your first source of information and advice.

Support groups can be a way for you to connect with others who may also be undergoing a similar treatment plan. Hospital-based or clinic-based support networks may also provide social work services, financial aid, nutritional advice, and other assistance.

What is VYXEOS?

VYXEOS (daunorubicin and cytarabine) liposome for injection 44 mg/100 mg is an intravenous (IV) chemotherapy used for the treatment of adults with certain types of newly-diagnosed acute myeloid leukemia (AML). These types include patients whose AML is related to previously received chemotherapy or radiation therapy (also called therapy-related AML, t-AML) and AML in patients who previously had certain types of blood disorders (also called AML with myelodysplasia-related changes, AML-MRC).

Important Safety Information

VYXEOS has different dosage recommendations from other medications that contain daunorubicin and/or cytarabine. Do not substitute VYXEOS for other daunorubicin and/or cytarabine-containing products.

Important Safety Information